| |
| |
|
| Insider
Information: |
Lim Jonathan E |
| Relationship: |
Chairman & CEO, Direct... |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
710,000 |
|
|
Indirect Shares
|
32,355,576 |
|
|
| Direct
Value |
$27,384,700 |
|
|
|
Indirect Value
|
$61,152,039 |
|
|
| Total
Shares |
33,065,576 |
|
|
| Total
Value |
$88,536,739 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -17.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Chief Executive Office... |
2010-01-12 |
710,000 |
|
0 |
Premium* |
|
|
Erasca, Inc. |
ERAS |
Chairman & CEO, Direct... |
2022-12-14 |
0 |
2023-12-06 |
32,355,576 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-12-06 |
4 |
B |
$1.72 |
$478,418 |
I/I |
278,150 |
12,899,360 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-12-05 |
4 |
B |
$1.69 |
$1,217,761 |
I/I |
721,850 |
12,899,360 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-10-05 |
4 |
B |
$2.03 |
$2,026,000 |
I/I |
1,000,000 |
19,456,216 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-06-08 |
4 |
B |
$2.75 |
$275,000 |
I/I |
100,000 |
18,396,216 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-03-28 |
4 |
B |
$2.84 |
$284,000 |
I/I |
100,000 |
18,296,216 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-01-10 |
4 |
B |
$3.86 |
$231,420 |
I/I |
60,000 |
20,256,222 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2022-12-14 |
4 |
B |
$4.99 |
$199,600 |
I/I |
40,000 |
20,196,222 |
2.64 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Chief Executive Officer |
• • – |
2010-01-12 |
4 |
OE |
$0.39 |
$11,700 |
D/D |
30,000 |
710,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2008-03-20 |
4 |
S |
$6.06 |
$1,515,000 |
D/D |
(250,000) |
680,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2008-03-19 |
4 |
OE |
$0.39 |
$89,700 |
D/D |
230,000 |
930,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-11-30 |
4 |
AS |
$8.06 |
$164,796 |
D/D |
(20,000) |
700,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-11-30 |
4 |
OE |
$0.39 |
$7,800 |
D/D |
20,000 |
720,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-10-31 |
4 |
AS |
$9.01 |
$225,850 |
D/D |
(25,000) |
700,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-10-31 |
4 |
OE |
$0.39 |
$9,750 |
D/D |
25,000 |
725,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-10-16 |
4 |
OE |
$0.45 |
$12,000 |
D/D |
26,690 |
700,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-09-28 |
4 |
AS |
$8.59 |
$219,524 |
D/D |
(25,000) |
673,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-09-28 |
4 |
OE |
$0.39 |
$9,750 |
D/D |
25,000 |
698,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-08-31 |
4 |
AS |
$8.70 |
$112,840 |
D/D |
(12,800) |
673,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-08-31 |
4 |
AS |
$8.30 |
$104,508 |
D/D |
(12,200) |
686,110 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-08-31 |
4 |
OE |
$0.39 |
$9,750 |
D/D |
25,000 |
698,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-07-31 |
4 |
OE |
$0.39 |
$7,800 |
D/D |
20,000 |
693,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-07-31 |
4 |
AS |
$8.12 |
$163,933 |
D/D |
(20,000) |
673,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-06-29 |
4 |
AS |
$9.16 |
$158,376 |
D/D |
(16,801) |
681,509 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-06-29 |
4 |
OE |
$0.39 |
$9,750 |
D/D |
25,000 |
698,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-06-29 |
4 |
AS |
$9.56 |
$78,594 |
D/D |
(8,199) |
673,310 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
